Vascular Perfusion Solutions, Inc

Vascular Perfusion Solutions (VPS), a Texas-based early-stage Medtech company, is revolutionizing organ transplantation with a focus on simplicity, ease of use, and accessibility in price through our flagship product, the VP.S ENCORE, a hypothermic machine perfusion device for prolonged cardiac graft preservation. This innovative device represents a groundbreaking advancement in heart preservation technology, surpassing conventional methods such as the ice-cooler. It has gained FDA breakthrough device designation in 2021 and undergone successful preclinical testing on over 100 hearts, including ovine, porcine, and human hearts donated for research

Cardiac preservation,biotechnology,medical device,oxygen perfusion,evidence based science,limb replantation,vascularized tissue perfusion,limb perfusion,biomedical engineering,vp.s encore,organ preservation,pediatrics,hypothermic machine perfusion,biomarker assessment,langendorff reperfusion,research innovation,internship opportunities,stem,orthotopic transplants,scientific collaborations,organ transport,portable cardiac preservation,isolated heart model,and oxygenated perfusate

Vascular perfusion solutions, inc operates in the Medical equipment manufacturing industry.

Vascular perfusion solutions, inc's revenue is 11m - 100m

Vascular perfusion solutions, inc has 11 - 50 employees.